Stay updated on Dose-escalation SAR440234 Clinical Trial
Sign up to get notified when there's something new on the Dose-escalation SAR440234 Clinical Trial page.

Latest updates to the Dose-escalation SAR440234 Clinical Trial page
- Check3 days agoChange DetectedThe NIH notice about its terminology transition and related updates is no longer displayed above the study record page, which continues to show a 403 Forbidden error.SummaryDifference1%

- Check9 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0 while the study record continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check16 days agoChange DetectedA notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the study page’s error message.SummaryDifference1%

- Check23 days agoChange DetectedThe ClinicalTrials.gov 403 error page’s footer revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check30 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check51 days agoChange DetectedThe study record view now shows a 403 Forbidden error, replacing the detailed study information with a generic error page. This change blocks access to the trial's content and related documentation in this view.SummaryDifference18%

Stay in the know with updates to Dose-escalation SAR440234 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dose-escalation SAR440234 Clinical Trial page.